Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

News Daily News

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Caitlin E. Cox

July 24, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Yael L. Maxwell

May 12, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Daily News

Overuse of CT Scans for Suspected Pulmonary Embolism Persists

Todd Neale

January 23, 2020

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

Advertisement

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Venous Stents: Long-term Follow-up Plus a New Contender

Overuse of CT Scans for Suspected Pulmonary Embolism Persists

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content